IFNG and Alzheimer disease: While IFN-γ increased in both AD progression and healthy aging, this direct comparison of AD with wild-type control at the 180-day time point demonstrates that the increase in disease is significantly more pronounced than that in healthy aging, a point that cannot be drawn from the comparison of the two separately-derived models in Figure 1.